QSC Tirzepatide (LY3298176) is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for type 2 diabetes research. This compound demonstrates superior efficacy in glucose control and weight management compared to selective GLP-1 receptor agonists.
The qsc tirzepatide molecule exhibits greater affinity for GIP receptors while maintaining significant activity at GLP-1 receptors. This unique dual mechanism has shown promising results in reducing hyperglycemia in research settings. The compound mimics natural GIP action at GIP receptors while providing the beneficial effects of GLP-1 agonism.
Our qsc tirzepatide is supplied as a high purity white powder (≥99%) with molecular formula C225H348N48O68 and molar mass of 4813.45. The product is carefully packaged to ensure stability and purity throughout storage and transportation.
For research purposes only. Not for human consumption. Proper storage conditions are essential for maintaining the stability of qsc tirzepatide. The compound should be stored dry and protected from light at 0-4°C for short term use or -20°C for long term preservation.